Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:testosterone undecanoate
go back to main search page
Accession:CHEBI:135741 term browser browse the term
Synonyms:related_synonym: Formula=C30H48O3;   InChI=1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1;   InChIKey=UDSFVOAUHKGBEK-CNQKSJKFSA-N;   SMILES=C[C@@]12[C@@]3([C@]([C@]4([C@@](CC3)(C)[C@H](CC4)OC(CCCCCCCCCC)=O)[H])(CCC1=CC(CC2)=O)[H])[H];   testosterone undecylate
 xref: CAS:5949-44-0;   Drug_Central:2608
 xref_mesh: MESH:C010792


show annotations for term's descendants           Sort by:
testosterone undecanoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ACE2 mRNA CTD PMID:19074003 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977 		JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA CTD PMID:19074003 NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968 		JBrowse link
G Afg1l AFG1 like ATPase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AFG1L mRNA CTD PMID:19074003 NCBI chr20:45,798,344...45,967,997
Ensembl chr20:45,798,349...45,967,906 		JBrowse link
G Ahctf1 AT hook containing transcription factor 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA CTD PMID:19074003 NCBI chr13:91,481,936...91,536,391
Ensembl chr13:91,481,936...91,536,391 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ALMS1 mRNA CTD PMID:19074003 NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005 		JBrowse link
G Alpk2 alpha-kinase 2 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA
testosterone undecanoate results in increased expression of ALPK2 mRNA		 CTD PMID:19074003 NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258 		JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AMMECR1 mRNA
testosterone undecanoate results in decreased expression of AMMECR1 mRNA		 CTD PMID:19074003 NCBI chr  X:106,465,982...106,571,382
Ensembl chr  X:106,466,699...106,571,487 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 increases expression ISO testosterone undecanoate results in increased expression of AMPD3 mRNA CTD PMID:19074003 NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887 		JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ANKDD1A mRNA CTD PMID:19074003 NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651 		JBrowse link
G Api5 apoptosis inhibitor 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of API5 mRNA CTD PMID:19074003 NCBI chr 3:80,378,096...80,403,259
Ensembl chr 3:80,378,096...80,403,264 		JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARHGAP23 mRNA
testosterone undecanoate results in increased expression of ARHGAP23 mRNA		 CTD PMID:19074003 NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504 		JBrowse link
G Arl9 ARF like GTPase 9 increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of ARL9 mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA		 CTD PMID:19074003 NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,157,586...31,166,699 		JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ASAP1 mRNA CTD PMID:19074003 NCBI chr 7:95,786,130...96,093,111
Ensembl chr 7:95,787,818...96,092,754 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AZGP1 mRNA
testosterone undecanoate results in decreased expression of AZGP1 mRNA		 CTD PMID:19074003 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091 		JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074 		JBrowse link
G Bbx BBX high mobility group box domain containing multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BBX mRNA CTD PMID:19074003 NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251 		JBrowse link
G Bcl2l14 Bcl2-like 14 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of BCL2L14 mRNA
testosterone undecanoate results in increased expression of BCL2L14 mRNA		 CTD PMID:19074003 NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086 		JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BTBD3 mRNA CTD PMID:19074003 NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038 		JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CCN3 mRNA
testosterone undecanoate results in decreased expression of CCN3 mRNA		 CTD PMID:19074003 NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019 		JBrowse link
G Cd86 CD86 molecule increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of CD86 mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CD86 mRNA		 CTD PMID:19074003 NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDC25C mRNA CTD PMID:19074003 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185 		JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CDC42BPB mRNA CTD PMID:19074003 NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:130,333,712...130,416,377 		JBrowse link
G Cdc42ep1 CDC42 effector protein 1 decreases expression ISO testosterone undecanoate results in decreased expression of CDC42EP1 mRNA CTD PMID:19074003 NCBI chr 7:110,395,287...110,403,203
Ensembl chr 7:110,395,332...110,403,200 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674 		JBrowse link
G Cep170b centrosomal protein 170B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CEP170B mRNA CTD PMID:19074003 NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658 		JBrowse link
G Cfap65 cilia and flagella associated protein 65 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CFAP65 mRNA CTD PMID:19074003 NCBI chr 9:76,459,211...76,494,199
Ensembl chr 9:76,459,211...76,494,128 		JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CHEK2 mRNA
testosterone undecanoate results in decreased expression of CHEK2 mRNA		 CTD PMID:19074003 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286 		JBrowse link
G Chodl chondrolectin decreases expression ISO testosterone undecanoate results in decreased expression of CHODL mRNA CTD PMID:19074003 NCBI chr11:17,654,137...17,676,450
Ensembl chr11:17,654,206...17,676,441 		JBrowse link
G Chp2 calcineurin-like EF hand protein 2 decreases expression ISO testosterone undecanoate results in decreased expression of CHP2 mRNA CTD PMID:19074003 NCBI chr 1:176,757,945...176,772,443
Ensembl chr 1:176,757,876...176,772,139 		JBrowse link
G Cimap1a ciliary microtubule associated protein 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CIMAP1A mRNA CTD PMID:19074003 NCBI chr 1:195,926,034...195,929,250
Ensembl chr 1:195,926,041...195,929,248 		JBrowse link
G Cntf ciliary neurotrophic factor increases expression ISO testosterone undecanoate results in increased expression of CNTF mRNA CTD PMID:19074003 NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of COL1A1 mRNA CTD PMID:19074003 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col22a1 collagen type XXII alpha 1 chain multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of COL22A1 mRNA
testosterone undecanoate results in increased expression of COL22A1 mRNA		 CTD PMID:19074003 NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462 		JBrowse link
G Corin corin, serine peptidase increases expression ISO testosterone undecanoate results in increased expression of CORIN mRNA CTD PMID:19074003 NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503 		JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CPEB3 mRNA CTD PMID:19074003 NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560 		JBrowse link
G Cpxcr1 CPX chromosome region, candidate 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CPXCR1 mRNA CTD PMID:19074003 NCBI chr  X:81,756,909...81,794,661 JBrowse link
G Crlf3 cytokine receptor-like factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CRLF3 mRNA CTD PMID:19074003 NCBI chr10:65,024,228...65,060,746
Ensembl chr10:65,023,388...65,060,670 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA CTD PMID:19074003 NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CSNK1A1 mRNA CTD PMID:19074003 NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA
testosterone undecanoate results in increased expression of CXCL10 mRNA		 CTD PMID:19074003 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA
testosterone undecanoate results in decreased expression of CYP17A1 mRNA		 CTD PMID:19074003 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Dap3 death associated protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA CTD PMID:19074003 NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:174,318,983...174,346,461 		JBrowse link
G Dcn decorin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DCN mRNA CTD PMID:19074003 NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270 		JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DDHD1 mRNA CTD PMID:19074003 NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952 		JBrowse link
G Dlgap2 DLG associated protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DLGAP2 mRNA CTD PMID:19074003 NCBI chr16:74,786,771...75,496,402
Ensembl chr16:74,791,509...75,496,407 		JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DNASE1L3 mRNA
testosterone undecanoate results in decreased expression of DNASE1L3 mRNA		 CTD PMID:19074003 NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317 		JBrowse link
G Dock8 dedicator of cytokinesis 8 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DOCK8 mRNA CTD PMID:19074003 NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474 		JBrowse link
G Dok5 docking protein 5 increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of DOK5 mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA		 CTD PMID:19074003 NCBI chr 3:159,515,886...159,652,811
Ensembl chr 3:159,515,893...159,652,810 		JBrowse link
G Dsg1 desmoglein 1 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DSG1 mRNA
testosterone undecanoate results in increased expression of DSG1 mRNA		 CTD PMID:19074003 NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ELOVL5 mRNA CTD PMID:19074003 NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA CTD PMID:19074003 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966 		JBrowse link
G Etnk1 ethanolamine kinase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ETNK1 mRNA CTD PMID:19074003 NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770 		JBrowse link
G Evi2b ecotropic viral integration site 2B increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of EVI2B mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of EVI2B mRNA		 CTD PMID:19074003 NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560 		JBrowse link
G Fam20a FAM20A, golgi associated secretory pathway pseudokinase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA CTD PMID:19074003 NCBI chr10:94,638,836...94,697,814
Ensembl chr10:94,642,850...94,697,672 		JBrowse link
G Far2 fatty acyl CoA reductase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA CTD PMID:19074003 NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:181,007,622...181,087,255 		JBrowse link
G Fbxl20 F-box and leucine-rich repeat protein 20 decreases expression ISO testosterone undecanoate results in decreased expression of FBXL20 mRNA CTD PMID:19074003 NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162 		JBrowse link
G Fcrl5 Fc receptor-like 5 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FCRL5 mRNA
testosterone undecanoate results in increased expression of FCRL5 mRNA		 CTD PMID:19074003 NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FERMT2 mRNA CTD PMID:19074003 NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811 		JBrowse link
G Fkbp6 FKBP prolyl isomerase family member 6 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FKBP6 mRNA
testosterone undecanoate results in increased expression of FKBP6 mRNA		 CTD PMID:19074003 NCBI chr12:21,318,251...21,390,350
Ensembl chr12:21,319,568...21,390,350 		JBrowse link
G Fmnl3 formin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FMNL3 mRNA CTD PMID:19074003 NCBI chr 7:130,454,270...130,505,626
Ensembl chr 7:130,454,275...130,505,626 		JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FNBP1 mRNA CTD PMID:19074003 NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881 		JBrowse link
G Fut1 fucosyltransferase 1 decreases expression ISO testosterone undecanoate results in decreased expression of FUT1 mRNA CTD PMID:19074003 NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616 		JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GDF10 mRNA
testosterone undecanoate results in decreased expression of GDF10 mRNA		 CTD PMID:19074003 NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343 		JBrowse link
G Gdpd3 glycerophosphodiester phosphodiesterase domain containing 3 increases expression ISO testosterone undecanoate results in increased expression of GDPD3 mRNA CTD PMID:19074003 NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063 		JBrowse link
G Glyr1 glyoxylate reductase 1 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GLYR1 mRNA CTD PMID:19074003 NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637 		JBrowse link
G Gpr135 G protein-coupled receptor 135 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GPR135 mRNA CTD PMID:19074003 NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GREB1 mRNA
testosterone undecanoate results in decreased expression of GREB1 mRNA		 CTD PMID:19074003 NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633 		JBrowse link
G Gzmk granzyme K increases expression ISO testosterone undecanoate results in increased expression of GZMK mRNA CTD PMID:19074003 NCBI chr 2:44,840,811...44,848,829
Ensembl chr 2:44,840,811...44,848,894 		JBrowse link
G Herc4 HECT and RLD domain containing E3 ubiquitin protein ligase 4 decreases expression ISO testosterone undecanoate results in decreased expression of HERC4 mRNA CTD PMID:19074003 NCBI chr20:25,329,972...25,404,657
Ensembl chr20:25,330,280...25,404,657 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HMMR mRNA
testosterone undecanoate results in increased expression of HMMR mRNA		 CTD PMID:19074003 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060 		JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 decreases expression ISO testosterone undecanoate results in decreased expression of HNRNPA3 mRNA CTD PMID:19074003 NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306 		JBrowse link
G Hoxc6 homeo box C6 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HOXC6 mRNA
testosterone undecanoate results in increased expression of HOXC6 mRNA		 CTD PMID:19074003 NCBI chr 7:134,138,017...134,148,899
Ensembl chr 7:134,135,502...134,148,392 		JBrowse link
G Hpcal4 hippocalcin-like 4 decreases expression ISO testosterone undecanoate results in decreased expression of HPCAL4 mRNA CTD PMID:19074003 NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase increases expression ISO testosterone undecanoate results in increased expression of HPGD mRNA CTD PMID:19074003 NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228 		JBrowse link
G Hspb9 heat shock protein family B (small) member 9 increases expression ISO testosterone undecanoate results in increased expression of HSPB9 mRNA CTD PMID:19074003 NCBI chr10:85,641,284...85,641,929
Ensembl chr10:85,641,284...85,641,929 		JBrowse link
G Htr7 5-hydroxytryptamine receptor 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HTR7 mRNA CTD PMID:19074003 NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626 		JBrowse link
G Ice2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ICE2 mRNA CTD PMID:19074003 NCBI chr 8:70,043,419...70,085,217
Ensembl chr 8:70,043,424...70,084,995 		JBrowse link
G Ifi30 IFI30, lysosomal thiol reductase increases expression ISO testosterone undecanoate results in increased expression of IFI30 mRNA CTD PMID:19074003 NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA
testosterone undecanoate results in increased expression of IGFBP3 mRNA		 CTD PMID:19074003 NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083 		JBrowse link
G Igsf1 immunoglobulin superfamily, member 1 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of IGSF1 mRNA
testosterone undecanoate results in decreased expression of IGSF1 mRNA		 CTD PMID:19074003 NCBI chr  X:129,069,891...129,085,331
Ensembl chr  X:129,069,896...129,085,139 		JBrowse link
G Igsf6 immunoglobulin superfamily, member 6 increases expression ISO testosterone undecanoate results in increased expression of IGSF6 mRNA CTD PMID:19074003 NCBI chr 1:175,610,167...175,620,662
Ensembl chr 1:175,610,167...175,620,722 		JBrowse link
G Inha inhibin subunit alpha multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INHA mRNA
testosterone undecanoate results in decreased expression of INHA mRNA		 CTD PMID:19074003 NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248 		JBrowse link
G Insl3 insulin-like 3 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INSL3 mRNA
testosterone undecanoate results in decreased expression of INSL3 mRNA		 CTD PMID:19074003 NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560 		JBrowse link
G Insl6 insulin-like 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of INSL6 mRNA CTD PMID:19074003 NCBI chr 1:227,069,958...227,073,493
Ensembl chr 1:227,069,958...227,073,493 		JBrowse link
G Itih4 inter-alpha-trypsin inhibitor heavy chain 4 increases expression ISO testosterone undecanoate results in increased expression of ITIH4 mRNA CTD PMID:19074003 NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708 		JBrowse link
G Katnal1 katanin catalytic subunit A1 like 1 increases expression ISO testosterone undecanoate results in increased expression of KATNAL1 mRNA CTD PMID:19074003 NCBI chr12:6,094,663...6,156,114
Ensembl chr12:6,102,836...6,157,553 		JBrowse link
G Kbtbd7 kelch repeat and BTB domain containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA CTD PMID:19074003 NCBI chr15:54,806,878...54,811,457
Ensembl chr15:54,806,873...54,811,687 		JBrowse link
G Kcnh7 potassium voltage-gated channel subfamily H member 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of KCNH7 mRNA CTD PMID:19074003 NCBI chr 3:47,329,338...47,822,122
Ensembl chr 3:47,338,501...47,822,195 		JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KDSR mRNA CTD PMID:19074003 NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108 		JBrowse link
G Klhl11 kelch-like family member 11 increases expression ISO testosterone undecanoate results in increased expression of KLHL11 mRNA CTD PMID:19074003 NCBI chr10:85,398,487...85,409,049
Ensembl chr10:85,398,487...85,409,049 		JBrowse link
G Klhl28 kelch-like family member 28 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL28 mRNA CTD PMID:19074003 NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164 		JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL4 mRNA
testosterone undecanoate results in decreased expression of KLHL4 mRNA		 CTD PMID:19074003 NCBI chr  X:79,429,193...79,719,482
Ensembl chr  X:79,622,113...79,719,480 		JBrowse link
G Klk13 kallikrein related-peptidase 13 increases expression ISO testosterone undecanoate results in increased expression of KLK13 mRNA CTD PMID:19074003 NCBI chr 1:94,165,381...94,177,002
Ensembl chr 1:94,165,381...94,177,002 		JBrowse link
G Limd1 LIM domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LIMD1 mRNA CTD PMID:19074003 NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:123,122,460...123,167,714 		JBrowse link
G Lingo1 leucine rich repeat and Ig domain containing 1 increases expression ISO testosterone undecanoate results in increased expression of LINGO1 mRNA CTD PMID:19074003 NCBI chr 8:57,011,272...57,193,496
Ensembl chr 8:57,010,007...57,196,544 		JBrowse link
G Lmntd1 lamin tail domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of LMNTD1 mRNA CTD PMID:19074003 NCBI chr 4:178,354,302...178,588,483
Ensembl chr 4:178,354,137...178,588,477 		JBrowse link
G Lrig2 leucine-rich repeats and immunoglobulin-like domains 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LRIG2 mRNA CTD PMID:19074003 NCBI chr 2:191,947,322...192,012,996
Ensembl chr 2:191,949,819...192,012,579 		JBrowse link
G Man2a1 mannosidase, alpha, class 2A, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MAN2A1 mRNA CTD PMID:19074003 NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349 		JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MBNL1 mRNA CTD PMID:19074003 NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368 		JBrowse link
G Mep1b meprin A subunit beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MEP1B mRNA CTD PMID:19074003 NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840 		JBrowse link
G Midn midnolin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MIDN mRNA CTD PMID:19074003 NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752 		JBrowse link
G Mro maestro multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRO mRNA
testosterone undecanoate results in decreased expression of MRO mRNA		 CTD PMID:19074003 NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044 		JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA CTD PMID:19074003 NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MTSS1 mRNA CTD PMID:19074003 NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968 		JBrowse link
G Mysm1 myb-like, SWIRM and MPN domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MYSM1 mRNA CTD PMID:19074003 NCBI chr 5:109,761,345...109,826,652
Ensembl chr 5:109,776,286...109,819,967 		JBrowse link
G Nacc2 NACC family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NACC2 mRNA CTD PMID:19074003 NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:8,883,065...8,946,660 		JBrowse link
G Ndfip1 Nedd4 family interacting protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NDFIP1 mRNA CTD PMID:19074003 NCBI chr18:30,265,808...30,316,068
Ensembl chr18:30,250,613...30,322,311 		JBrowse link
G Nexn nexilin (F actin binding protein) multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NEXN mRNA CTD PMID:19074003 NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342 		JBrowse link
G Nid1 nidogen 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267 		JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NSG1 mRNA CTD PMID:19074003 NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514 		JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of OLFML3 mRNA
testosterone undecanoate results in decreased expression of OLFML3 mRNA		 CTD PMID:19074003 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050 		JBrowse link
G Opn5 opsin 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OPN5 mRNA CTD PMID:19074003 NCBI chr 9:18,368,393...18,416,098
Ensembl chr 9:18,368,416...18,415,476 		JBrowse link
G Or10j2 olfactory receptor family 10 subfamily J member 2 multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OR10J1 mRNA
testosterone undecanoate results in increased expression of OR10J1 mRNA		 CTD PMID:19074003 NCBI chr13:85,723,300...85,724,290
Ensembl chr13:85,719,234...85,724,767 		JBrowse link
G Osbpl10 oxysterol binding protein-like 10 increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of OSBPL10 mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OSBPL10 mRNA		 CTD PMID:19074003 NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAK3 mRNA CTD PMID:19074003 NCBI chr  X:107,116,308...107,374,342
Ensembl chr  X:107,260,898...107,368,314 		JBrowse link
G Pappa pappalysin decreases expression
multiple interactions		 ISO testosterone undecanoate results in decreased expression of PAPPA mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAPPA mRNA		 CTD PMID:19074003 NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666 		JBrowse link
G Pard6b par-6 family cell polarity regulator beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PARD6B mRNA CTD PMID:19074003 NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:156,790,540...156,811,622 		JBrowse link
G Pcdh7 protocadherin 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA CTD PMID:19074003 NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051
Ensembl chr14:52,475,610...52,902,051 		JBrowse link
G Pde1c phosphodiesterase 1C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PDE1C mRNA CTD PMID:19074003 NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219 		JBrowse link
G Pkp4 plakophilin 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PKP4 mRNA CTD PMID:19074003 NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474 		JBrowse link
G Plagl1 PLAG1 like zinc finger 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PLAGL1 mRNA CTD PMID:19074003 NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228 		JBrowse link
G Poglut1 protein O-glucosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of POGLUT1 mRNA CTD PMID:19074003 NCBI chr11:62,198,600...62,226,446
Ensembl chr11:62,198,513...62,226,434 		JBrowse link
G Ppp2r2c protein phosphatase 2, regulatory subunit B, gamma multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PPP2R2C mRNA
testosterone undecanoate results in increased expression of PPP2R2C mRNA		 CTD PMID:19074003 NCBI chr14:73,846,547...73,931,489
Ensembl chr14:73,846,547...73,931,864 		JBrowse link
G Prkab1 protein kinase AMP-activated non-catalytic subunit beta 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PRKAB1 mRNA CTD PMID:19074003 NCBI chr12:40,588,140...40,598,673
Ensembl chr12:40,588,211...40,598,661 		JBrowse link
G Prkca protein kinase C, alpha increases expression ISO testosterone undecanoate results in increased expression of PRKCA mRNA CTD PMID:19074003 NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012 		JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTBP2 mRNA CTD PMID:19074003 NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506 		JBrowse link
G Ptger2 prostaglandin E receptor 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGER2 mRNA CTD PMID:19074003 NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714 		JBrowse link
G Ptges prostaglandin E synthase multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGES mRNA
testosterone undecanoate results in decreased expression of PTGES mRNA		 CTD PMID:19074003 NCBI chr 3:14,177,892...14,189,236 JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA CTD PMID:19074003 NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of RAB1A mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RAB1A mRNA		 CTD PMID:19074003 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248 		JBrowse link
G Rapgef6 Rap guanine nucleotide exchange factor 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAPGEF6 mRNA CTD PMID:19074003 NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211 		JBrowse link
G Recql RecQ like helicase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RECQL mRNA CTD PMID:19074003 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945 		JBrowse link
G Rftn2 raftlin family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RFTN2 mRNA CTD PMID:19074003 NCBI chr 9:56,651,617...56,707,830
Ensembl chr 9:56,630,460...56,707,810 		JBrowse link
G Rln1 relaxin 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RLN1 mRNA CTD PMID:19074003 NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:227,079,966...227,082,882 		JBrowse link
G Rnaseh1 ribonuclease H1 decreases expression ISO testosterone undecanoate results in decreased expression of RNASEH1 mRNA CTD PMID:19074003 NCBI chr 6:45,282,849...45,292,258
Ensembl chr 6:45,282,854...45,292,236 		JBrowse link
G Rnf216 ring finger protein 216 increases expression
multiple interactions		 ISO testosterone undecanoate results in increased expression of RNF216 mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNF216 mRNA		 CTD PMID:19074003 NCBI chr12:11,454,752...11,576,305
Ensembl chr12:11,454,797...11,576,304 		JBrowse link
G Rnft1 ring finger protein, transmembrane 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA CTD PMID:19074003 NCBI chr10:71,310,052...71,322,507
Ensembl chr10:71,310,104...71,323,778 		JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HLA-DQB1 mRNA CTD PMID:19074003 NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597 		JBrowse link
G Rtn4 reticulon 4 decreases expression ISO testosterone undecanoate results in decreased expression of RTN4 mRNA CTD PMID:19074003 NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686 		JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA CTD PMID:19074003 NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545 		JBrowse link
G Scaf4 SR-related CTD-associated factor 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SCAF4 mRNA CTD PMID:19074003 NCBI chr11:29,460,479...29,521,153
Ensembl chr11:29,465,106...29,521,153 		JBrowse link
G Senp1 SUMO specific peptidase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SENP1 mRNA CTD PMID:19074003 NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598 		JBrowse link
G Serpinb3 serpin family B member 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SERPINB3 mRNA CTD PMID:19074003 NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682 		JBrowse link
G Sfrp5 secreted frizzled-related protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SFRP5 mRNA CTD PMID:19074003 NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:241,006,762...241,011,224 		JBrowse link
G Skic3 SKI3 subunit of superkiller complex multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SKIC3 mRNA CTD PMID:19074003 NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:5,631,635...5,751,626 		JBrowse link
G Slc16a9 solute carrier family 16, member 9 multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SLC16A9 mRNA
testosterone undecanoate results in decreased expression of SLC16A9 mRNA		 CTD PMID:19074003 NCBI chr20:18,335,862...18,377,125
Ensembl chr20:18,335,862...18,377,022 		JBrowse link
G Slc25a2 solute carrier family 25 member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA CTD PMID:19074003 NCBI chr18:29,452,943...29,456,324
Ensembl chr18:29,453,582...29,460,383 		JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106 		JBrowse link
G Slc6a5 solute carrier family 6 member 5 increases expression ISO testosterone undecanoate results in increased expression of SLC6A5 mRNA CTD PMID:19074003 NCBI chr 1:99,645,389...99,697,016
Ensembl chr 1:99,645,389...99,697,010 		JBrowse link
G Smyd2 SET and MYND domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SMYD2 mRNA CTD PMID:19074003 NCBI chr13:101,425,270...101,466,576
Ensembl chr13:101,425,273...101,466,576 		JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SNRPN mRNA CTD PMID:19074003 NCBI chr 1:111,101,327...111,123,400
Ensembl chr 1:111,101,329...111,123,634 		JBrowse link
G Sobp sine oculis binding protein homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SOBP mRNA CTD PMID:19074003 NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541 		JBrowse link
G Spin4 spindlin family, member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPIN4 mRNA CTD PMID:19074003 NCBI chr  X:59,888,728...59,892,817
Ensembl chr  X:59,891,581...59,892,330 		JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPTBN1 mRNA CTD PMID:19074003 NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507 		JBrowse link
G Srgn serglycin multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SRGN mRNA
testosterone undecanoate results in decreased expression of SRGN mRNA		 CTD PMID:19074003 NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406 		JBrowse link
G Srp68 signal recognition particle 68 increases expression ISO testosterone undecanoate results in increased expression of SRP68 mRNA CTD PMID:19074003 NCBI chr10:101,481,213...101,508,035
Ensembl chr10:101,481,212...101,508,035 		JBrowse link
G Stxbp5l syntaxin binding protein 5L multiple interactions
increases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of STXBP5L mRNA
testosterone undecanoate results in increased expression of STXBP5L mRNA		 CTD PMID:19074003 NCBI chr11:63,334,667...63,654,270
Ensembl chr11:63,334,667...63,657,014 		JBrowse link
G Syt11 synaptotagmin 11 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SYT11 mRNA CTD PMID:19074003 NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964 		JBrowse link
G Tfdp2 transcription factor Dp-2 decreases expression ISO testosterone undecanoate results in decreased expression of TFDP2 mRNA CTD PMID:19074003 NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682 		JBrowse link
G Thpo thrombopoietin increases expression ISO testosterone undecanoate results in increased expression of THPO mRNA CTD PMID:19074003 Ensembl chr11:80,182,820...80,188,167 JBrowse link
G Tmem217 transmembrane protein 217 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM217 mRNA CTD PMID:19074003 NCBI chr20:7,584,177...7,619,023
Ensembl chr20:7,592,627...7,619,111
Ensembl chr20:7,592,627...7,619,111 		JBrowse link
G Tmem225 transmembrane protein 225 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM225 mRNA CTD PMID:19074003 NCBI chr 8:40,497,483...40,500,041
Ensembl chr 8:40,497,483...40,500,041 		JBrowse link
G Tmem35a transmembrane protein 35A multiple interactions
decreases expression		 ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA
testosterone undecanoate results in decreased expression of TMEM35A mRNA		 CTD PMID:19074003 NCBI chr  X:97,503,350...97,514,198
Ensembl chr  X:97,503,350...97,514,197 		JBrowse link
G Tmod2 tropomodulin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720 		JBrowse link
G Tnrc6b trinucleotide repeat containing adaptor 6B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TNRC6B mRNA CTD PMID:19074003 NCBI chr 7:112,252,351...112,469,829
Ensembl chr 7:112,252,359...112,461,790 		JBrowse link
G Tra2a transformer 2 alpha decreases expression
multiple interactions		 ISO testosterone undecanoate results in decreased expression of TRA2A mRNA
[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRA2A mRNA		 CTD PMID:19074003 NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712 		JBrowse link
G Trmt13 tRNA methyltransferase 13 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRMT13 mRNA CTD PMID:19074003 NCBI chr 2:204,533,630...204,547,711
Ensembl chr 2:204,533,632...204,546,843 		JBrowse link
G Tubb2a tubulin, beta 2A class IIa increases expression ISO testosterone undecanoate results in increased expression of TUBB2A mRNA CTD PMID:19074003 NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714 		JBrowse link
G Ubap1 ubiquitin-associated protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA CTD PMID:19074003 NCBI chr 5:56,520,722...56,561,153
Ensembl chr 5:56,520,743...56,561,152 		JBrowse link
G Ube2d3 ubiquitin-conjugating enzyme E2D 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 NCBI chr 2:223,868,397...223,899,606
Ensembl chr 2:223,868,730...223,898,081 		JBrowse link
G Unc13c unc-13 homolog C increases expression ISO testosterone undecanoate results in increased expression of UNC13C mRNA CTD PMID:19074003 NCBI chr 8:74,247,026...74,697,629
Ensembl chr 8:74,247,899...74,673,223 		JBrowse link
G Xiap X-linked inhibitor of apoptosis decreases expression ISO testosterone undecanoate results in decreased expression of XIAP mRNA CTD PMID:19074003 NCBI chr  X:120,890,537...120,938,413
Ensembl chr  X:120,897,907...120,934,700 		JBrowse link
G Xylt1 xylosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of XYLT1 mRNA CTD PMID:19074003 NCBI chr 1:171,643,925...171,929,774
Ensembl chr 1:171,643,925...171,926,783 		JBrowse link
G Yeats2 YEATS domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of YEATS2 mRNA CTD PMID:19074003 NCBI chr11:80,743,134...80,829,253
Ensembl chr11:80,743,134...80,829,208 		JBrowse link
G Zcchc7 zinc finger CCHC-type containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZCCHC7 mRNA CTD PMID:19074003 NCBI chr 5:58,992,558...59,173,308
Ensembl chr 5:58,993,290...59,173,300 		JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZEB2 mRNA CTD PMID:19074003 NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157 		JBrowse link
G Zfand6 zinc finger AN1-type containing 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFAND6 mRNA CTD PMID:19074003 NCBI chr 1:138,581,002...138,652,052
Ensembl chr 1:138,581,002...138,651,939 		JBrowse link
G Zfp518a zinc finger protein 518A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA CTD PMID:19074003 NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979 		JBrowse link
G Zfp638 zinc finger protein 638 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF638 mRNA CTD PMID:19074003 NCBI chr 4:116,355,934...116,475,051
Ensembl chr 4:116,402,428...116,479,845 		JBrowse link
G Zfr zinc finger RNA binding protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFR mRNA CTD PMID:19074003 NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:61,137,611...61,200,322 		JBrowse link
G Zkscan7 zinc finger with KRAB and SCAN domains 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA CTD PMID:19074003 NCBI chr 8:122,501,938...122,519,600
Ensembl chr 8:122,502,218...122,519,600 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19901
    chemical entity 19899
      atom 19899
        nonmetal atom 19822
          carbon atom 19775
            organic molecular entity 19775
              lipid 18001
                steroid 14731
                  steroid ester 1300
                    testosterone undecanoate 182
Path 2
Term Annotations click to browse term
  CHEBI ontology 19901
    subatomic particle 19899
      composite particle 19899
        hadron 19899
          baryon 19899
            nucleon 19899
              atomic nucleus 19899
                atom 19899
                  main group element atom 19838
                    p-block element atom 19838
                      carbon group element atom 19778
                        carbon atom 19775
                          organic molecular entity 19775
                            organic molecule 19728
                              organic cyclic compound 19519
                                organic polycyclic compound 17313
                                  steroid 14731
                                    steroid ester 1300
                                      testosterone undecanoate 182
paths to the root